Freeman Roy Lester
Insider CIK 1799732 · IKT Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| IKT Inhibikase Therapeutics, I | A Award deriv | 2025-02-14 | 2025-02-19 | 22,640 | — | $0 | 22,640 | SEC↗ |
| IKT Inhibikase Therapeutics, I | A Award deriv | 2025-01-21 | 2025-01-22 | 1,138 | — | $0 | 1,138 | SEC↗ |
| IKT Inhibikase Therapeutics, I | D To issuer deriv | 2025-01-21 | 2025-01-22 | 3,780 | — | $0 | 0 | SEC↗ |
| IKT Inhibikase Therapeutics, I | A Award deriv | 2025-01-21 | 2025-01-22 | 3,780 | — | $0 | 3,780 | SEC↗ |
| IKT Inhibikase Therapeutics, I | D To issuer deriv | 2025-01-21 | 2025-01-22 | 6,667 | — | $0 | 0 | SEC↗ |
| IKT Inhibikase Therapeutics, I | A Award deriv | 2025-01-21 | 2025-01-22 | 6,667 | — | $0 | 6,667 | SEC↗ |
| IKT Inhibikase Therapeutics, I | D To issuer deriv | 2025-01-21 | 2025-01-22 | 6,667 | — | $0 | 0 | SEC↗ |
| IKT Inhibikase Therapeutics, I | A Award deriv | 2025-01-21 | 2025-01-22 | 6,667 | — | $0 | 6,667 | SEC↗ |
| IKT Inhibikase Therapeutics, I | D To issuer deriv | 2025-01-21 | 2025-01-22 | 30,000 | — | $0 | 0 | SEC↗ |
| IKT Inhibikase Therapeutics, I | A Award deriv | 2025-01-21 | 2025-01-22 | 30,000 | — | $0 | 30,000 | SEC↗ |
| IKT Inhibikase Therapeutics, I | D To issuer deriv | 2025-01-21 | 2025-01-22 | 21,854 | — | $0 | 0 | SEC↗ |
| IKT Inhibikase Therapeutics, I | A Award deriv | 2025-01-21 | 2025-01-22 | 21,854 | — | $0 | 21,854 | SEC↗ |
| IKT Inhibikase Therapeutics, I | D To issuer deriv | 2025-01-21 | 2025-01-22 | 1,138 | — | $0 | 0 | SEC↗ |
| IKT Inhibikase Therapeutics, I | A Award deriv | 2025-01-03 | 2025-01-07 | 172,191 | — | $0 | 172,191 | SEC↗ |
| IKT Inhibikase Therapeutics, I | A Award deriv | 2025-01-03 | 2025-01-07 | 316,647 | — | $0 | 316,647 | SEC↗ |
| IKT Inhibikase Therapeutics, I | A Award deriv | 2025-01-03 | 2025-01-07 | 344,452 | — | $0 | 344,452 | SEC↗ |
| IKT Inhibikase Therapeutics, I | A Award deriv | 2024-07-16 | 2024-07-18 | 30,000 | — | $0 | 30,000 | SEC↗ |
| IKT Inhibikase Therapeutics, I | A Award deriv | 2023-06-30 | 2023-07-05 | 6,667 | — | $0 | 6,667 | SEC↗ |
| IKT Inhibikase Therapeutics, I | A Award deriv | 2022-06-24 | 2022-06-28 | 40,000 | — | $0 | 40,000 | SEC↗ |
| IKT Inhibikase Therapeutics, I | A Award deriv | 2021-06-25 | 2021-06-29 | 22,677 | — | $0 | 22,677 | SEC↗ |
| IKT Inhibikase Therapeutics, I | A Award deriv | 2020-12-22 | 2020-12-29 | 6,825 | — | $0 | 6,825 | SEC↗ |